CRVO
CervoMed Inc.
$3.55
-0.14 (-3.79%)
At close · Jul 2
Market Cap
$32.87M
Shares
9,258,719
Price & Indicators
Indicators
Price
Panels
Event markers
20d MA
50d MA
200d MA
Earnings
Filing
Insider
Congress
Investor day
Close$3.55
Open$3.64
Day$3.45–3.69
52W$2.13–13.13
Avg vol 30d11.3M
Short int344K · 3.7% float · 1.0d
Short vol45%
Last earningsMay 18, 2026
DataJan 2020–Jul 2026
Filing10-Q · May 15
Equibles Rating
blended score · not investment advice
Overall
Neutral
Technical · trend & momentum
Neutral
◦
50 / 200-day cross
no cross
−
Price vs 200-day avg
−38% below
+
Price vs 50-day avg
+4% above
◦
RSI (14)
52 · neutral
+
MACD trend
positive
−
52-week position
13% · near low
Sentiment · smart money
Bearish
◦
Trend (MA cross)
50d $3 › 200d $6 — 200d above 50d
−
Institutional flow
-25% holders QoQ · +6 funds added
+
Insider flow
Net +$3.0M over 90 days · 0% sells
−
Short interest
3.71% of float · ▲ +30.8% MoM · 1.0 days cover
◦
Volume signal
Volume near normal
◦
Institution breadth
36 holders — mid 3-yr range
Fundamentals
Fair
−
Revenue growth
−59% Y/Y
+
Gross margin
2%, expanding
◦
EPS growth
+5% Y/Y
−
Free cash flow
$-23.9M
+
Balance sheet
net cash $6.6M
Blended from price, positioning & fundamentals · daily-close · not investment advice.
Up next
Next earnings call
Aug 17, 2026
Est · unconfirmed
· in 6 wks
FQ3-26 quarter ends
~Sep 30, 2026
Est
filed May 15, 2026
Technicals
trend & momentum for long-term holders Neutral
50 / 200-day cross
no cross
Neutral
Price vs 200-day avg
−38% below
Bearish
Price vs 50-day avg
+4% above
Bullish
RSI (14)
52 · neutral
Neutral
MACD trend
positive
Bullish
52-week position
13% · near low
Bearish
Market signals — smart money & positioning
Bearish · 2 of 6
Trend (MA cross)
No cross
50d $3 › 200d $6 — 200d above 50d
Institutional flow
Distributing
-25% holders QoQ · +6 funds added
Insider flow
Accumulating
Net +$3.0M over 90 days · 0% sells
Short interest
Rising
3.71% of float · ▲ +30.8% MoM · 1.0 days cover
Volume signal
Normal
Volume near normal
Institution breadth
Steady
36 holders — mid 3-yr range
Price context
position in its 52-week range
52-wk low $2
Now $4 · 13%
52-wk high $13
vs 200-day avg -38%
vs 50-day avg +4%
Illustrative technical + ownership context — a signal mix, not investment advice.
Versus peers
Biotechnology — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
CRVO
this stock
CervoMed Inc.
|
$32.87M | -55.1% | -58.9% | — | 3.7% |
|
AKTX
Akari Therapeutics Plc
|
$953.21B | -9.9% | — | — | 0.0% |
|
ONC
BeOne Medicines Ltd.
|
$470.30B | -2.0% | +22179.2% | 957.1 | 0.1% |
|
VRTX
Vertex Pharmaceuticals Inc / Ma
|
$134.02B | +16.5% | +46.2% | 31.3 | 1.8% |
|
REGN
Regeneron Pharmaceuticals, Inc.
|
$69.80B | -15.1% | +20.8% | 16.3 | 3.2% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every sectionOwnership
Short & Settlement
Smart Money
Financials
Filings
Earnings & Events
Performance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| CRVO | +6.0% | +19.5% | -54.9% | +14.5% | -55.1% |
| SPY | +1.4% | -1.3% | +8.0% | -0.3% | +9.2% |
| vs SPY | +4.5% | +20.8% | -62.9% | +14.8% | -64.3% |